Home
University of Bergen
Centre for Cancer Biomarkers CCBIO

News archive for Centre for Cancer Biomarkers CCBIO

The cover of the 100 year anniverary book for the Norwegian Society of Pathology.
100th Anniversary Symposium for the Norwegian Society of Pathology (05.12.2023)
The Norwegian Society of Pathology celebrated the first 100 years with a symposium on Updates and Future of Pathology. The event was supported by CCBIO and also celebrated with a history book covering the Society and its activities through 1923-2023.
Marta sitting in the lab.
One year in Boston (04.12.2023)
CCBIO PhD candidate Marta Espevold Hjelmeland in the Krakstad group spends the second year of her PhD program in Boston.
Portrait of Lars A. Akslen next to the Helse Vest Research Award diploma.
Prestigious recognitions to Lars A. Akslen and CCBIO (04.12.2023)
The regional health authority Helse Vest’s Research Award 2023 goes to Professor Lars Andreas Akslen and CCBIO for ground-breaking research on cancer biomarkers. Akslen has also been subject to another prestigious recognition this fall, as he was recently elected as member of the Academia Europaea.
Mari Halle standing in the park outside of Solstrand Hotel.
Investigating new treatment strategies for cervical cancer (03.12.2023)
Mari Kyllesø Halle received a frame allocation of NOK 8 million in the Researcher Projects 2023 call from the Norwegian Cancer Association, for the project "Decoding the Landscape of Cancer Vulnerabilities in high-risk Cervical Carcinomas to detect new treatment strategies." CCBIO is proud to see this CCBIO Masterclass alumna as a project leader for the first time.
McCormack in management group of new COST action (01.12.2023)
Emmet McCormack will be part of the new COST Action IMMUNO-model, where a network of scientists involved in the development and implementation of preclinical models evaluating the response and toxicity induced by immunotherapies, is challenged to expand our knowledge in their mechanisms of action and improve the survival and quality of life of cancer patients.